Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)
China Will Do What Is Needed to Boost Growth: Street
28:14 - Bill Street of State Street Global Advisors talks with Anna Edwards about the boost to Chinese manufacturing from stimulus measures and the seven-year high hit by the Shanghai Composite. He speaks on “On The Move.” (Source: Bloomberg)
  • Challenger Muhammadu Buhari Wins Nigeria's Presidency
  • Parity for Euro by End of the Year: BNP Paribas
  • ECB to Review Lifeline to Greek Banks